10-K: Turning Point Brands Reports Strong 2025 Growth, Modern Oral Drives Sales

Turning Point Brands, Inc. announced a significant increase in total net sales and gross profit for 2025, primarily fueled by robust growth in its modern oral products segment, despite a decline in Zig-Zag product sales.

Summary

• Total net sales increased by $102.4 million, or 28.4%, to $463.062 million for the year ended December 31, 2025, compared to the prior year.
• The Stokers products segment saw net sales surge by $116.3 million, or 69.1%, driven predominantly by $107.7 million in modern oral product growth.
• Gross profit rose by $62.7 million, or 31.1%, reaching $264.314 million, with the gross profit margin improving to 57.1% from 55.9% in 2024, mainly due to higher margin contributions from modern oral products and MST.
• Net income attributable to Turning Point Brands, Inc. increased by 22.9% to $58.165 million in 2025 from $47.326 million in 2024.
• Adjusted EBITDA grew to $119.522 million in 2025, up from $104.459 million in 2024.
• Cash on hand significantly increased to $222.8 million as of December 31, 2025, compared to $46.2 million at the end of 2024.
• The company successfully remediated a previously identified material weakness in internal control over financial reporting related to ineffective information technology general controls as of December 31, 2025.
• The CDS reportable segment was classified as discontinued operations and divested on January 2, 2025, resulting in no loss from discontinued operations in 2025 compared to a $7.5 million loss in 2024.
• Issued $300.0 million of 7.625% Senior Secured Notes due 2032 in February 2025, using proceeds to redeem the existing 5.625% Senior Secured Notes due 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, driven by significant growth in the modern oral segment and improved profitability, despite some challenges in the Zig-Zag segment and increased operating expenses. The remediation of internal control weaknesses and strong cash position further bolster confidence.

Positives

• Consolidated net sales increased by 28.4% to $463.062 million in 2025.
• Stokers products segment net sales grew by 69.1%, primarily due to $107.7 million in modern oral product growth.
• Consolidated gross profit increased by 31.1% to $264.314 million, with an improved gross profit margin of 57.1%.
• Net income attributable to Turning Point Brands, Inc. rose 22.9% to $58.165 million.
• Adjusted EBITDA increased to $119.522 million, demonstrating strong operational performance.
• Cash on hand significantly increased to $222.8 million, enhancing liquidity.
• The material weakness in internal control over financial reporting was successfully remediated by December 31, 2025.
• The company's asset-light business model, with approximately 75% of net sales derived from outsourced production, contributes to favorable margins and high free cash flow conversion.
• Strong brand recognition with Zig-Zag as the #1 premium and overall rolling paper in the U.S. (33% market share) and Stokers as the #1 discount and overall chewing tobacco brand (34.1% market share).
• Strategic investments in new product categories like modern oral nicotine (FRE, ALP joint venture) are yielding significant growth.
• The company's expertise in navigating complex regulatory environments, including the FDA's PMTA process, is a competitive advantage, with $34.8 million invested in applications.

Negatives

• Zig-Zag products segment net sales decreased by 7.2% ($13.9 million) in 2025, primarily due to a $15.2 million decline in U.S. papers and wraps.
• Zig-Zag gross profit decreased by 10.0%, with margins declining to 53.7% from 55.4% due to imposed tariffs and a shift to lower-margin products.
• Selling, general and administrative expenses increased significantly by 38.1% ($46.6 million), mainly due to increased shipping and selling costs related to modern oral sales.
• Operating income as a percentage of net sales decreased to 20.6% from 22.4%, primarily due to an increase in unallocated corporate expenses.
• Unallocated corporate costs increased by 34.3% ($18.6 million), largely driven by joint venture related expenses.
• Interest expense, net, increased by $3.5 million (24.9%) due to the issuance of higher-rate 2032 Notes and a higher outstanding principal amount.
• The company recognized a $5.5 million loss from its equity method investment in GWO.
• A $1.2 million loss on extinguishment of debt was incurred from the redemption of the 2026 Notes.
• The U.S. Supreme Court ruling in February 2026, prohibiting tariffs under IEEPA, does not provide a refund mechanism for previously paid tariffs, and a new blanket 10% tariff was imposed under the Trade Act of 1974, which could increase import costs.
• The company faces risks from declining sales of tobacco products overall, intense competition from better-capitalized companies, and competition from illicit sources.

Risks

• Declining sales of tobacco products and expected continuing decline in the tobacco industry overall.
• Dependence on a small number of key third-party suppliers and producers (e.g., Swedish Match, RTI).
• Possibility of being unable to identify or contract with new suppliers or producers in the event of supply disruptions.
• Risk that licenses to use certain brands or trademarks (e.g., Zig-Zag) may be terminated, challenged, or restricted, including a 5-year non-compete clause post-termination.
• Failure to maintain consumer brand recognition and loyalty or to anticipate and respond to changes in consumer preferences.
• Reliance on relationships with several large retailers and national chains for product distribution.
• Intense competition from larger, better-capitalized competitors, including big tobacco companies and those utilizing advanced technology like AI.
• Competition from illicit sources and the damage caused by counterfeit or unauthorized products to brand equity and sales volume.
• Contamination of tobacco supply or products, or damage to inventory (e.g., December 2023 tornado damage to a third-party warehouse).
• Uncertainty and continued evolution of the markets for novel nicotine and cannabinoid products.
• Potential for product recalls due to quality issues, contamination, or regulatory requirements.
• Difficulties or liabilities arising from investments in businesses, including joint ventures like ALP and equity method investments like GWO.
• Substantial and increasing regulation and changes in FDA enforcement priorities, including potential flavor bans, nicotine reduction, and premarket authorization requirements.
• Marketing denials of products by the FDA, which has broad regulatory powers.
• Many products contain nicotine, considered a highly addictive substance, leading to potential regulatory actions.
• Requirement to maintain compliance with Master Settlement Agreement (MSA) escrow accounts.
• Possible significant increases in federal, state, and local tobaccoand nicotine-related taxes.
• Sensitivity of end-customers to increased sales taxes and adverse economic conditions, including inflation and declines in purchasing power.
• Possible increasing international control and regulation, such as the World Health Organization's FCTC and U.S. Foreign Corrupt Practices Act (FCPA).
• Failure to comply with environmental, health, and safety regulations.
• Imposition of significant tariffs on imports into the U.S., as seen with the recent blanket 10% tariff under the Trade Act of 1974.
• Lack of extensive scientific information regarding the long-term health effects of certain substances in novel products (e.g., e-cigarettes, vaporizers, modern oral nicotine).
• Significant product liability litigation against the tobacco industry.
• Substantial amount of indebtedness ($300.0 million 2032 Notes) and restrictive covenants in debt agreements.
• Credit rating and ability to access well-functioning capital markets.
• Our certificate of incorporation limits ownership by 'Restricted Investors' (e.g., RTI competitors) to 14.9%, which may affect liquidity and voting rights.
• Future sales of common stock in the public market (including through the ATM Program) could reduce stock price and dilute ownership.
• Issuance of preferred stock could adversely affect the voting power or value of common stock.
• Business may be damaged by events outside of control, such as epidemics, political upheavals, natural disasters, or macroeconomic conditions.
• Adverse impact of climate change and related legal and regulatory requirements.
• Reliance on information technology and the risk of cybersecurity and privacy breaches, including those exacerbated by artificial intelligence.
• Failure to manage growth effectively.
• Failure to successfully identify, negotiate, and complete suitable acquisition opportunities or integrate acquisitions.
• Fluctuations in results due to promotional and sales incentives.
• Exchange rate fluctuations, particularly for Euro-denominated inventory purchases.
• Departure of key management personnel or inability to attract and retain talent.
• Infringement on or misappropriation of intellectual property.
• Third-party claims of intellectual property infringement.
• Impairment of intangible assets, including trademarks and goodwill.

Future Outlook

The company anticipates continued growth by investing in organic initiatives, pursuing strategic acquisitions and joint ventures across all product categories, and expanding internationally. It plans to introduce new products in attractive, growing markets, particularly within its papers and MYO wraps businesses, leveraging its e-commerce capabilities. The company expects to benefit from the evolving cannabinoid market and its regulatory compliance infrastructure to act as a consolidator in the OTP industry. However, the regulatory landscape, including potential FDA actions on flavors and nicotine, and changes in U.S. trade policies, introduces uncertainty regarding future costs and market access.

Management Comments

• Graham Purdy, President and CEO, certified that the Annual Report on Form 10-K does not contain any untrue statement of a material fact or omit to state a material fact, and that financial statements fairly present the financial condition, results of operations, and cash flows.
• Andrew Flynn, Chief Financial Officer, certified the accuracy of the financial statements and the effectiveness of disclosure controls and internal controls over financial reporting.
• Management believes there are meaningful opportunities to grow by investing in organic growth, acquisitions and joint ventures across all product categories.
• Management estimates that Zig-Zag is the #1 brand in the Canadian market.
• Management believes its asset-light model provides marketplace flexibility, allows for favorable margins, and generates high free cash flow conversion.
• Management believes it has a competitive advantage due to its experience navigating the relevant regulatory environment and has increased investments in regulatory teams.
• Management believes that its vision is built upon the idea that adult consumers, when presented with responsibly marketed and high-quality options, will, in large part, prefer products with a lower risk profile than others.

Industry Context

StockSavvy.ai notes that Turning Point Brands operates in dynamic and evolving markets. The alternative smoking accessories market is experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, with the U.S. legal cannabis market projected to grow from $30 billion in 2024 to $39 billion by 2029. The Other Tobacco Products (OTP) industry, while showing steady consumer unit annualized volumes in 2025, faces long-term declines in overall tobacco consumption. The regulatory environment, particularly from the FDA, continues to be a significant factor, with ongoing premarket review processes (PMTA) and potential for new restrictions on flavors and nicotine. Industry consolidation, as evidenced by Philip Morris International's acquisition of Swedish Match, intensifies competition, requiring companies like Turning Point Brands to leverage strong brands, innovation, and distribution networks to maintain market share against larger, better-capitalized competitors.

Comparison to Industry Standards

• Zig-Zag is the #1 premium and #1 overall rolling paper in the U.S. with approximately 33% total market share, outperforming competitors like Republic Tobacco, L.P. and HBI International in this category.
• Zig-Zag is also the #1 brand in the Canadian market for rolling papers, based on management estimates, indicating strong international positioning.
• Zig-Zag holds a 35% share of the overall cigar wraps category and 68% of the HTL cigar wraps sub-category, maintaining a market leader position against major competitors like Good Times USA, LLC and New Image Global, Inc.
• Stokers MST is among the fastest-growing brands and holds an 8.1% share of the total U.S. MST non-pouch market, competing with larger players such as Swedish Match, American Snuff Company, LLC, Swisher International Group, Inc., and U.S. Smokeless Tobacco Company.
• Stokers is the #1 discount and #1 overall brand in the chewing tobacco industry with approximately a 34.1% market share, surpassing competitors like Swedish Match, American Snuff Company, LLC, and Swisher International Group, Inc.
• The company collectively holds a 38.0% market share in chewing tobacco, solidifying its position as the #1 marketer in this segment.
• The company's early entry and differentiation with the Stokers 12 oz. MST tub packaging format has established it as the market leader with over 55% of the tub market as of 2025, demonstrating successful innovation compared to competitors who later introduced similar formats.
• The company's investment of $34.8 million in FDA PMTA applications positions it to navigate regulatory hurdles, potentially creating barriers for smaller competitors lacking similar infrastructure.

Management Changes

Corporate Governance

Legal Proceedings

• A purported stockholder lawsuit (Paul-Emile Berteau) relating to the merger of Standard Diversified, Inc. with a TPB subsidiary was settled and dismissed with prejudice on December 12, 2023. The company recorded a $4.0 million receivable and corresponding gain on settlement in 2023, with funds received in January 2024.
• The company is subject to significant product liability litigation common in the tobacco industry, with potential for substantial punitive and compensatory damages, though probable losses are not currently estimable.
• Ongoing litigation may divert management's attention and resources, impacting business and operations.

Related Party Transactions

• On January 2, 2025, the company contributed its former CDS segment (South Beach Brands LLC) to General Wireless Operations, Inc. (GWO) in exchange for a 49% equity interest. GWO is majority-owned by Standard General, LP, and the company accounts for its interest in GWO under the equity method.
• The company has long-standing exclusive distribution agreements with Republic Technology International SAS (RTI), an affiliate of one of its competitors, for Zig-Zag cigarette papers and related accessories. Approximately $84.7 million of Zig-Zag net sales in 2025 were generated from products sold through these license agreements.
• The company has a manufacturing and distribution agreement with Swedish Match (a division of Philip Morris International Inc.), which is also a competitor, for the exclusive manufacturing of its loose-leaf chewing tobacco products.
• In September 2024, a wholly-owned subsidiary acquired a 50% stake in ALP Supply Co., LLC (ALP), a joint venture with Last Country Ventures, LLC, for selling and distributing tobacco-free white pouch nicotine products. The company provides additional financing and is the exclusive product provider to ALP.
• In August 2025, the company and Standard General, LP amended the GWO purchase option held by the company, delaying the company's ability to exercise the purchase option until August 2027.
• On July 14, 2025, a third-party investor subscribed $11.0 million for an interest in Interchange IC's parent company, which contributed the investment to Interchange IC, a consolidated captive insurance company.

Stakeholder Impact

• Shareholders: Benefited from increased net income and diluted EPS, continued cash dividends ($0.30 per share in 2025), and an increased share repurchase authorization ($200.0 million remaining). However, future stock sales under the ATM Program could dilute ownership.
• Employees: Benefited from a decrease in voluntary turnover rate (13.3% in 2025 vs. 16.6% in 2024), 89 internal promotions, comprehensive benefit programs, and training and talent development initiatives.
• Customers: Continued access to a wide range of branded products through an extensive distribution network (220,000 retail locations), with new product introductions and category expansions.
• Suppliers: Maintained long-standing relationships with key suppliers like RTI and Swedish Match, although dependence on a small number of suppliers poses a risk.
• Creditors: The company's financial condition is affected by its $300.0 million 2032 Notes and the 2023 ABL Facility, with covenants that restrict certain operations and payments. The increase in cash on hand improves the company's ability to service debt.
• Regulatory Bodies: The company continues to invest heavily in regulatory compliance, particularly with FDA PMTA processes, and is subject to increasing federal, state, and local regulations, including potential flavor bans and tax increases.

Next Steps

• Continue to grow share of existing product lines, both domestically and internationally.
• Expand into adjacent product categories through innovation and new partnerships, with a focus on papers and MYO wraps businesses.
• Strategically introduce new products in attractive, growing markets.
• Leverage existing sales infrastructure and expand e-commerce distribution capabilities.
• Pursue strategic acquisitions and joint ventures to consolidate fragmented markets and expand product offerings.
• ALP intends to broaden its portfolio in 2026, including the introduction of 12 mg strength tobacco-free white pouch nicotine products.
• The option for Turning Point Brands Canada to acquire SBB's distribution business becomes exercisable in March 2027.
• The company's ability to exercise the GWO purchase option is delayed until August 2027.

Key Dates

Recommendation

The company demonstrated strong financial performance in 2025, with significant increases in total net sales, gross profit, and net income, primarily driven by the high-growth modern oral products segment. The successful remediation of a material internal control weakness and a substantial increase in cash on hand enhance operational stability and liquidity. While the Zig-Zag segment experienced a decline and regulatory risks persist, the company's strategic focus on innovation, category expansion, and a robust distribution network, coupled with its expertise in navigating complex regulatory environments, positions it for continued growth. The current valuation, considering the strong Adjusted EBITDA and positive outlook for modern oral and cannabinoid-related markets, suggests an attractive entry point for long-term investors.

Keywords

Tobacco, Nicotine, Cannabinoid, SEC Filing, 10-K, Financial Results, Annual Report, Turning Point Brands, Zig-Zag, Stokers, Modern Oral, PMTA, Cybersecurity, Consumer Products, Distribution, Acquisitions, Debt, Share Repurchase, Dividends